Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Stop Big Pharma Profiteering

EU Governments - Protect our Meds not Their Monopolies
EU Governments - Protect our Meds not Their Monopolies
EU Governments - Protect our Meds not Their Monopolies

Read, watch, share

Statement |
24 February 2014
Intellectual property and trade
European Union

MSF response to European Parliament proposals of EU enforcement of European trademarks on goods in transit

3 min
Press release |
09 April 2013
Intellectual property and trade Research and development
European UnionIndia

As clock ticks towards agreement, EU-India free trade deal puts millions of lives at risk

5 min
Nearly 2,000 People Living With HIV along with MSF & other civil society organisations rallied in the streets of New Delhi at the start of the EU-India summit. They warned that harmful provisions in a trade deal being negotiated between the EU and India could severely hinder access to affordable medicine for people in developing countries. Photograph by Siddharth Singh
Press release
Press release |
13 March 2013
Intellectual property and trade
European UnionIndia

India under pressure from Europe to sign off on trade deal that will harm access to medicines

4 min
Press release |
04 July 2012
Intellectual property and trade
European Union

EU Parliament Rejects ACTA; Allowing for Continued Access to Generic Medicines in Developing Countries

Press release |
25 May 2012
Intellectual property and trade Research and development
European Union

US and EU Derailing Ten-year Process to Create Health Research & Development Convention

Nearly 2,000 People Living With HIV along with MSF & other civil society organisations rallied in the streets of New Delhi at the start of the EU-India summit. They warned that harmful provisions in a trade deal being negotiated between the EU and India could severely hinder access to affordable medicine for people in developing countries. Photograph by Siddharth Singh
Press release
Press release |
10 February 2012
HIV/AIDS Intellectual property and trade
European UnionIndia

EU-India Trade Deal Could Cut Medicines Lifeline for People in Developing Countries

4 min
As India and the European Union prepare to meet at a New Delhi summit to finalize a Free Trade Agreement (FTA) under negotiation since 2007, Médecins Sans Frontières / Doctors Without Borders (MSF), the Treatment Action Campaign (TAC), SECTION27 and He-Tic held a picket to warn that harmful provisions in the agreement could have a severely negative impact on access to medicine for people in developing countries. Photograph by Borrie Lagrange
Feature story
Feature story |
10 February 2012
HIV/AIDS Intellectual property and trade
South AfricaEuropean Union

Photos from Global Actions Ahead Of EU-India FTA Summit

Events |
07 December 2011
Intellectual property and trade
European Union

Seminar on local production and access to medical products

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury